Maso V - Search Results

1

Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes.

Calgarotto AK, Longhini AL, Pericole de Souza FV, Duarte ASS, Ferro KP, Santos I, Maso V, Olalla Saad ST, Torello CO. Calgarotto AK, et al. Among authors: maso v. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211002647. doi: 10.1177/15347354211002647. Integr Cancer Ther. 2021. PMID: 33754891 Free PMC article.

2

Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells.

Calgarotto AK, Maso V, Junior GCF, Nowill AE, Filho PL, Vassallo J, Saad STO. Calgarotto AK, et al. Among authors: maso v. Sci Rep. 2018 Feb 22;8(1):3459. doi: 10.1038/s41598-018-21516-5. Sci Rep. 2018. PMID: 29472583 Free PMC article.

3

The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes.

Alvarez MC, Maso V, Torello CO, Ferro KP, Saad STO. Alvarez MC, et al. Among authors: maso v. Clin Epigenetics. 2018 Nov 8;10(1):139. doi: 10.1186/s13148-018-0563-3. Clin Epigenetics. 2018. PMID: 30409182 Free PMC article.

4

Multitarget effects of quercetin in leukemia.

Maso V, Calgarotto AK, Franchi GC Jr, Nowill AE, Filho PL, Vassallo J, Saad ST. Maso V, et al. Cancer Prev Res (Phila). 2014 Dec;7(12):1240-50. doi: 10.1158/1940-6207.CAPR-13-0383. Epub 2014 Oct 7. Cancer Prev Res (Phila). 2014. PMID: 25293876

5

Differential effects of nitrostyrene derivatives on myelopoiesis involve regulation of C/EBPα and p38MAPK activity.

Bartels M, Calgarotto AK, Martens AC, Maso V, da Silva SL, Bierings MB, de Souza Queiroz ML, Coffer PJ. Bartels M, et al. Among authors: maso v. PLoS One. 2014 Mar 10;9(3):e90586. doi: 10.1371/journal.pone.0090586. eCollection 2014. PLoS One. 2014. PMID: 24614182 Free PMC article.

6

Koninginins, phospholipase A2 inhibitors from endophytic fungus Trichoderma koningii.

Souza AD, Rodrigues-Filho E, Souza AQ, Pereira JO, Calgarotto AK, Maso V, Marangoni S, Da Silva SL. Souza AD, et al. Among authors: maso v. Toxicon. 2008 Feb;51(2):240-50. doi: 10.1016/j.toxicon.2007.09.009. Epub 2007 Sep 29. Toxicon. 2008. PMID: 17983638

7

Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.

da Silva SL, Calgarotto AK, Maso V, Damico DC, Baldasso P, Veber CL, Villar JA, Oliveira AR, Comar M Jr, Oliveira KM, Marangoni S. da Silva SL, et al. Among authors: maso v. Eur J Med Chem. 2009 Jan;44(1):312-21. doi: 10.1016/j.ejmech.2008.02.043. Epub 2008 Mar 12. Eur J Med Chem. 2009. PMID: 18423943

8

Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment.

Di Cecco C, Monticelli J, Di Bella S, Di Maso V, Luzzati R. Di Cecco C, et al. Among authors: di maso v. J Chemother. 2024 Feb;36(1):31-34. doi: 10.1080/1120009X.2023.2247205. Epub 2023 Aug 21. J Chemother. 2024. PMID: 37602423

9

In Reference to Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma.

Maso V, Morvan JB, Dagain A, Beucler N. Maso V, et al. Laryngoscope. 2023 Nov;133(11):E64-E65. doi: 10.1002/lary.30913. Epub 2023 Jul 27. Laryngoscope. 2023. PMID: 37497851 No abstract available.

10

Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy.

Balestra E, Barbi E, Ceconi V, Di Maso V, Conversano E, Pennesi M. Balestra E, et al. Among authors: di maso v. Pediatr Nephrol. 2024 Jan;39(1):309-314. doi: 10.1007/s00467-023-06088-5. Epub 2023 Jul 26. Pediatr Nephrol. 2024. PMID: 37493956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page